- Home
- EXEL vs AAL Comparison
EXEL vs AAL Comparison
Compare EXEL & AAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- AAL
- Stock Information
- Founded
- EXEL 1994
- AAL 1930
- Country
- EXEL United States
- AAL United States
- Employees
- EXEL N/A
- AAL N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- AAL Air Freight/Delivery Services
- Sector
- EXEL Health Care
- AAL Consumer Discretionary
- Exchange
- EXEL Nasdaq
- AAL Nasdaq
- Market Cap
- EXEL 10.4B
- AAL 8.7B
- IPO Year
- EXEL 2000
- AAL N/A
- Fundamental
- Price
- EXEL $40.35
- AAL $12.57
- Analyst Decision
- EXEL Buy
- AAL Hold
- Analyst Count
- EXEL 22
- AAL 14
- Target Price
- EXEL $44.00
- AAL $14.46
- AVG Volume (30 Days)
- EXEL 2.3M
- AAL 79.4M
- Earning Date
- EXEL 10-28-2025
- AAL 10-23-2025
- Dividend Yield
- EXEL N/A
- AAL N/A
- EPS Growth
- EXEL 81.76
- AAL N/A
- EPS
- EXEL 2.08
- AAL 0.86
- Revenue
- EXEL $2,230,005,000.00
- AAL $54,250,000,000.00
- Revenue This Year
- EXEL $9.19
- AAL $1.40
- Revenue Next Year
- EXEL $12.54
- AAL $6.03
- P/E Ratio
- EXEL $19.56
- AAL $14.49
- Revenue Growth
- EXEL 10.73
- AAL 1.50
- 52 Week Low
- EXEL $25.17
- AAL $8.50
- 52 Week High
- EXEL $49.62
- AAL $19.10
- Technical
- Relative Strength Index (RSI)
- EXEL 61.73
- AAL 46.80
- Support Level
- EXEL $38.37
- AAL $12.16
- Resistance Level
- EXEL $40.78
- AAL $12.82
- Average True Range (ATR)
- EXEL 1.01
- AAL 0.45
- MACD
- EXEL 0.41
- AAL -0.12
- Stochastic Oscillator
- EXEL 91.21
- AAL 21.09
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.